comparemela.com

Latest Breaking News On - Intravaccbv - Page 1 : comparemela.com

Intravacc Awarded US$ 633K CARB-X Funding to Develop a

Intravacc Announces Review Publication of OMV-based

Mucosal route induces both localized and systemic immunityIntravacc is currently developing 3 OMV-based intranasal vaccinesArticle published in.

CEPI partners with Intravacc to develop an intranasal, broadly protective Betacoronavirus vaccine

Intravacc Awarded US$14 6 Million NIH/NIAID Contract to Develop Intranasal Gonorrhea Vaccine

Intravacc announces formation of Scientific Advisory Board

Intravacc announces formation of Scientific Advisory Board News provided by Share this article BILTHOVEN, the Netherlands, Feb. 23, 2021 /PRNewswire/   Intravacc, a world leader in translational research and development of vaccines, today announced the formation of a Scientific Advisory Board ( SAB ), chaired by Intravacc s Chief Scientific Officer Virgil Schijns and further comprising scientific leaders in the fields of vaccinology, infectious diseases and oncology. Intravacc s SAB will be consulted to help define the proper vaccine strategies and solutions to establish an impact on public health supported by convincing scientific clinical data. The SAB will also advise on the company s research strategy and approaches to optimize therapy effectiveness and added value.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.